Breast cancer metastasis: markers and models
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view--it suggests that metastatic capacity is a late, acquired event in tumorigenesis. Others have proposed the idea that breast cancer is intrinsically a systemic disease. New molecular technologies, such as DNA microarrays, support the idea that metastatic capacity might be an inherent feature of breast tumours. These data have important implications for prognosis prediction and our understanding of metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune cells were shown to both enhance and inhibit malignant cells proliferation, migration, and metastasis [125-128].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [125]
In the citing paper
“Chemical gradients play an important role in tumor cell invasion of metastatic cancer [195,196] as it significantly directs the migration and differentiation of tumor cells.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [196]
In the citing paper
“Metastasis is the leading cause of death from breast cancer1, 37-39.”
From Liposomal Formulation of HIF-1α Inhibitor Echinomycin Eliminates Established Metastases of Triple-negative Breast Cancer (2020) · cites this paper as [1]
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“ERBB2 is overexpressed due to gene amplification in 15–30% of human breast cancer”
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Research works printed but not linked: 2
- Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumour embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
- Leighton, J. Inherent malignancy of cancer cells possibly limited by genetically differing cells in the same tumour. Acta Cytol. 9, 138–140 (1965).
Cited by
Items 801–900 of 1,003
Survival in breast cancer is familial
Hemminki, K., Ji, J., Försti, A., Sundquist, J., & Lenner, P. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9692-7 · Cited by 37
Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer
Alshareeda, A. T., Rakha, E. A., Nolan, C. C., Ellis, I. O., & Green, A. R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2083-8 · Cited by 37
Drews‐Elger, K., Brinkman, J. A., Miller, P., Shah, S. H., Harrell, J. C., Silva, T. G. D., Ao, Z., Schlater, A., Azzam, D. J., Diehl, K. M., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2887-9 · Cited by 37
“Lesions were found in lymph nodes and lungs, which are common sites of metastasis observed in breast cancer patients [59].”
BackgroundPrion protein binding to HOP modulates the migration and invasion of colorectal cancer cells
de Lacerda, T. C. S., Costa‐Silva, B., Giudice, F. S., Dias, M. V. S., de Oliveira, G. P., Teixeira, B. L., Santos, T. G., & Martins, V. R. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9788-8 · Cited by 38
Targeting Lyn regulates Snail family shuttling and inhibits metastasis
Thaper, D., Vahid, S., Nip, K. M., Moskalev, I., Shan, X., Frees, S., Roberts, M. E., Ketola, K., Harder, K. W., Gregory, C. Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.5 · Cited by 39
2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells
Ismail, I. A., Kang, H. S., Lee, H., Chang, H., Yun, J., Lee, C. W., Kim, N. H., Kim, H. S., Yook, J. I., Hong, S., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2388-7 · Cited by 38
“The main cause of cancer death is not the primary tumor but its metastases at distal sites [35].”
BackgroundData-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells
Yadavalli, S., Jayaram, S., Manda, S. S., Madugundu, A. K., Nayakanti, D. S., Tan, T. Z., Bhat, R., Rangarajan, A., Chatterjee, A., Gowda, H., et al. (2017) · Scientific Reports · doi:10.1038/srep43710 · Cited by 43
A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer
Xu, C., Wang, Y., Zhu, W., Li, Y., Liu, L., Yin, G., & Gao, P. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.03.010 · Cited by 36
Franich, A. A., Živković, M. D., Ćoćić, D., Petrović, B., Milovanović, M., Arsenijević, A., Milovanović, J., Arsenijević, D., Stojanović, B., Djuran, M. I., et al. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01695-w · Cited by 36
The tissue expression of MCT3, MCT8, and MCT9 genes in women with breast cancer
Sohrabi, E., Moslemi, M., Rezaie, E., Nafissi, N., Khaledi, M., Afkhami, H., Fathi, J., & Zekri, A. (2021) · Genes & Genomics · doi:10.1007/s13258-021-01116-w · Cited by 40
KYNU, a novel potential target that underpins CD44‐promoted breast tumour cell invasion
Al‐Mansoob, M., Gupta, I., Rusyniak, R. S., & Ouhtit, A. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16296 · Cited by 36
PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
Rinne, S. S., Orlova, A., & Максимилианович, Т. В. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073663 · Cited by 36
Alothaim, T., Charbonneau, M., & Tang, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-90527-6 · Cited by 37
He, Y., Xu, Y., Huang, Y., Quang, H., Xia, X., Zhao, H., Xiao, Y., Lu, W. P., & Yu, J. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.112249 · Cited by 36
Zhao, B., Xu, B., Hu, W., Song, C., Wang, F., Liu, Z., Ye, M., Zou, H., & Miao, Q. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.08.007 · Cited by 36
Guerreiro, P. S., Corvacho, E., Costa, J. G., Saraiva, N., Fernandes, A. S., Castro, M., Miranda, J. P., & Oliveira, N. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12979 · Cited by 39
Do, M. T., Chai, T. F., Casey, P. J., & Wang, M. (2017) · Oncogene · doi:10.1038/onc.2017.183 · Cited by 36
Aukes, K., Forsman, C. L., Brady, N. J., Astleford, K., Blixt, N. C., Sachdev, D., Jensen, E. D., Mansky, K. C., & Schwertfeger, K. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185736 · Cited by 41
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients
on behalf of the SUCCESS Study Group, Alunni‐Fabbroni, M., Majunke, L., Trapp, E. K., Tzschaschel, M. L. J., Mahner, S., Fasching, P. A., Fehm, T. N., Schneeweiß, A., Beck, T., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4020-7 · Cited by 37
Vargas, P. P., Cooper, S., Sero, J., Bousgouni, V., Arias-García, M., & Bakal, C. (2017) · Scientific Data · doi:10.1038/sdata.2017.18 · Cited by 37
Leung, H.-W., Wang, Z., Yue, G. G., Zhao, S., Lee, J. K.-M., Fung, K., Leung, P., Lau, C. B., & Tan, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.020 · Cited by 35
Gao, X., Yang, X., Wang, B., Liu, S., & Wang, X. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.5055 · Cited by 35
Luan, M., Yu, L., Li, Y., Pan, W., Gao, X., Wan, X., Li, N., & Tang, B. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b03146 · Cited by 36
Vallabhaneni, K. C., Penfornis, P., Xing, F., Hassler, Y., Adams, K. V., Mo, Y., Watabe, K., & Pochampally, R. R. (2017) · Oncotarget · doi:10.18632/oncotarget.22371 · Cited by 36
miR-1284 Inhibits the Growth and Invasion of Breast Cancer Cells by Targeting ZIC2
Zhang, P., Yang, F., Luo, Q. F., Yan, D., & Sun, S. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15242763477504 · Cited by 35
Maroni, P., Matteucci, E., Luzzati, A., Perrucchini, G. G., Bendinelli, P., & Desiderio, M. A. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1240-1 · Cited by 37
“Thus, the gene signature associated with poor prognosis facilitates the emergence of metastatic cells in the primary tumor, but the specific set of genes associated with bone metastasis seems responsible for the cellular activities necessary for metastatisation [6-8].”
BackgroundOPG/RANKL/RANK Pathway as a Therapeutic Target in Cancer
McGrath, E. E. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318229421f · Cited by 39
Wang, J. J., Sanderson, B. J. S., & Zhang, W. Y. (2012) · PubMed · Cited by 35
Kometiani, P. A., Liu, L., & Askari, A. (2004) · Cited by 35
Zheng, G., Shen, Z., Chen, H., Liu, J., Jiang, K., Fan, L., Jia, L., & Shao, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.091 · Cited by 35
Mitchell, M. I., Ma, J., Carter, C. L., & Loudig, O. D. (2022) · Cancers · doi:10.3390/cancers14143350 · Cited by 37
Hehlgans, S., Petraki, C., Reichert, S., Cordes, N., Rödel, C. M., & Rödel, F. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.006 · Cited by 36
Influence of the interaction between long noncoding RNAs and hypoxia on tumorigenesis
Dong, J., Xu, J., Wang, X., & Jin, B. (2015) · Tumor Biology · doi:10.1007/s13277-015-4457-0 · Cited by 35
Diffuse fluorescence fiber probe for in vivo detection of circulating cells
Pera, V., Tan, X., Runnels, J. M., Sardesai, N., Lin, C. P., & Niedre, M. J. (2017) · Journal of Biomedical Optics · doi:10.1117/1.jbo.22.3.037004 · Cited by 34
Coutermarsh‐Ott, S. L., Broadway, K. M., Scharf, B. E., & Allen, I. C. (2017) · Oncotarget · doi:10.18632/oncotarget.16830 · Cited by 37
“In our present study, we chose to focus on lung metastasis, as the lung is the most common metastasis site of breast cancer found at autopsy and lung metastasis is also a prominent feature of the 4T1 model [25, 37].”
BackgroundBarron, G. A., Goua, M., Wahle, K. W. J., & Bermano, G. (2017) · Oncology Reports · doi:10.3892/or.2017.5803 · Cited by 34
Hodge, D. Q., Cui, J., Gamble, M. J., & Guo, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-19364-4 · Cited by 35
Witt, K., Ligtenberg, M. A., Conti, L., Lanzardo, S., Ruiu, R., Wallmann, T., Tufvesson-Stiller, H., Chambers, B. J., Rolny, C., Lladser, Á., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0572 · Cited by 35
“However, relapse and metastases remain the most common causes of death among women with breast cancer (3).”
BackgroundGao, X.-H., Zhang, Y., Zhang, Z., Guo, S., Chen, X., & Guo, Y. (2020) · Scientific Reports · doi:10.1038/s41598-019-56571-z · Cited by 34
Ashokkumar, N., Meera, S., Anandan, P., Murthy, M. Y. B., Kalaivani, K. S., Alahmadi, T. A., Alharbi, S. A., Raghavan, S. S., & Jayadhas, S. A. (2022) · BioMed Research International · doi:10.1155/2022/8616535 · Cited by 34
RetractedHuang, F., Dai, S.-Z., Xu, W.-T., Xiong, W., Sun, Y., Huang, Y., Wang, J.-Y., Lin, Y., Chen, H., Tan, G., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106613 · Cited by 35
Parathyroid Hormone Related Protein (PTHrP) in Tumor Progression
Kremer, R. B., Li, J., Camirand, A., & Karaplis, A. C. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0254-1_12 · Cited by 34
Recent advances in metastasis research
Molloy, T., & Veer, L. V. ‘. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.019 · Cited by 34
Adam, M., Matt, S., Christian, S., Hess‐Stumpp, H., Haegebarth, A., Hofmann, T. G., & Algire, C. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1104441 · Cited by 36
Fry, S. A., Robertson, C. E., Swann, R., & Dwek, M. V. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.66 · Cited by 34
Bao, C., Kim, M. C., Chen, J., Song, J., Ko, H. W., & Lee, H. J. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b02195 · Cited by 34
Østevold, K., Meléndez, A. V., Lehmann, F., Schmidt, G., Aktories, K., & Schwan, C. (2017) · Oncotarget · doi:10.18632/oncotarget.20805 · Cited by 34
Subhawa, S., Chewonarin, T., & Banjerdpongchai, R. (2020) · Molecules · doi:10.3390/molecules25051196 · Cited by 34
Harnessing the evolving CRISPR/Cas9 for precision oncology
Li, T., Li, S., Kang, Y., Zhou, J., & Yi, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05570-4 · Cited by 39
“This provides crucial insights for clinical research on precision treatment [247–249].”
BackgroundXiong, Y., Ye, T., Wang, M., Xia, Y., Wang, N., Song, X., Wang, F., Liu, L., Zhu, Y., Yang, F., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366385 · Cited by 33
Functional elements demarcated by histone modifications in breast cancer cells
Choe, M. K., Hong, C. P., Park, J., Seo, S. H., & Roh, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.042 · Cited by 34
Klose, P., Weise, C., Bondzio, A., Multhaup, G., Einspanier, R., Gruber, A. D., & Klopfleisch, R. (2011) · Journal of Proteome Research · doi:10.1021/pr200112q · Cited by 33
Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion
Gu, S., Liang, H., Qi, D., Mao, L., Mao, G., Li, Q., & Zhang, S. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s163346 · Cited by 33
“4 7 Therefore, it is important to identify novel therapeutic targets and factors that could be potential biomarkers for the early diagnosis and prognosis of patients with breast cancer.”
BackgroundLiang, J., Zhang, X., Yuan, J., Zhang, H., Liu, D., Hao, J., Ji, W., Wu, X., & Chen, D. (2018) · Phytotherapy Research · doi:10.1002/ptr.6250 · Cited by 33
Ovarian metastasis from breast cancer: a comprehensive review
Tian, W., Zhou, Y., Wu, M. H., Yao, Y., & Deng, Y. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-018-02007-5 · Cited by 33
miR‐4732‐5p promotes breast cancer progression by targeting TSPAN 13
Wang, Y., Zhao, S., Yuan, X., Liu, Y., Zhang, K., Wang, J., Zhu, J., & Ma, R. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14145 · Cited by 33
Quantitative microimmunohistochemistry for the grading of immunostains on tumour tissues
Kashyap, A., Khartchenko, A. F., Pati, P., Gabrani, M., Schraml, P., & Kaigala, G. V. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0386-3 · Cited by 36
LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung
Zhang, J., Chen, J., Wo, D., Yan, H., Liu, P., Ma, E., Li, L., Zheng, L., Chen, D., Yu, Z., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3557 · Cited by 33
Analysis of circulating non-coding RNAs in a non-invasive and cost-effective manner
Wang, Y., Trinh, M. P., Zheng, Y., Guo, K., Jimenez, L. A., & Zhong, W. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.07.001 · Cited by 37
Lin, C., Yang, X., Li, H., Zou, Y., Mohammad, I. S., Rong, H., Rao, Y., Song, J. T., Leung, S. S. Y., & Hu, H. (2021) · Nanoscale · doi:10.1039/d1nr00032b · Cited by 33
Subramaiam, H., Chu, W.-L., Radhakrishnan, A. K., Chakravarthi, S., Selvaduray, K. R., & Kok, Y.-Y. (2021) · Nutrients · doi:10.3390/nu13072320 · Cited by 30
Teng, Y., Loveless, R., Benson, E. M., Sun, L., Shull, A. Y., & Shay, C. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02083-6 · Cited by 36
HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy
Lee, Y.-H., Liu, X., Qiu, F., O'Connor, T. R., Yen, Y., & Ann, D. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121207 · Cited by 38
“Early diagnosis and effective use of adjuvant therapies are required to improve patient survival [1, 2].”
Li, H., Huang, F., Fan, L., Jiang, Y., Wang, X., Li, J., Wang, Q., Pan, H., Sun, J., Cao, X., et al. (2013) · Oncogene · doi:10.1038/onc.2013.408 · Cited by 33
Zhang, W., Zeng, F., Wu, X., Zhang, X., & Jiang, R. (2009) · International Joint Conferences on Bioinformatics, Systems Biology and Intelligent Computing · doi:10.1109/ijcbs.2009.23 · Cited by 33
Moon, W. K., Lee, Y., Huang, Y., Lee, S. H., Bae, M. S., Yi, A., Huang, C., & Chang, R. (2017) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2017.06.001 · Cited by 34
Identification of cell-surface markers for detecting breast cancer cells in ovarian tissue
Peters, I., Hilders, C. G. J. M., Sier, C. F. M., Vahrmeijer, A. L., Smit, V. T. H. B. M., Trimbos, J. B., & Kuppen, P. J. K. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4036-7 · Cited by 32
Alatawi, F. S., & Faridi, U. A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21975 · Cited by 32
“Metastasis refers to the ability of cancer cells to extend from the primary site where they initiate development to other parts of the body to form secondary tumours [58].”
BackgroundRetractedMicroRNA regulation of epithelial plasticity in cancer
D’Amato, N. C., Howe, E. N., & Richer, J. K. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.054 · Cited by 37
Regulation of the TGF-β pathway by deubiquitinases in cancer
Liu, S., de Boeck, M., van Dam, H., & ten Dijke, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.05.001 · Cited by 33
Long intergenic non-coding RNA expression signature in human breast cancer
Zhang, Y., Wagner, E. K., Guo, X., May, I., Cai, Q., Zheng, W., He, C., & Long, J. (2016) · Scientific Reports · doi:10.1038/srep37821 · Cited by 35
Beebe, S. J., Celestine, M. J., Bullock, J. L., Sandhaus, S., Arca, J. F., Cropek, D. M., Ludvig, T. A., Foster, S. R., Clark, J. S., Beckford, F. A., et al. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110907 · Cited by 32
Limited inhibition of multiple nodes in a driver network blocks metastasis
Yesilkanal, A. E., Yang, D., Valdespino, A., Tiwari, P., Sabino, A. U., Nguyen, L. C., Lee, J., Xie, X.-H., Sun, S., Dann, C., et al. (2021) · eLife · doi:10.7554/elife.59696 · Cited by 34
Alimohammadi, M., Rahimi, A. A. R., Faramarzi, F., Golpour, M., Jafari-Shakib, R., Alizadeh‐Navaei, R., & Rafiei, A. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00817-8 · Cited by 32
Intratumoral phenotypic heterogeneity as an encourager of cancer invasion
Shin, Y., Han, S., Chung, E., & Chung, S. H. (2014) · Integrative Biology · doi:10.1039/c4ib00022f · Cited by 32
Park, C., Kim, D., & Sheen, Y. Y. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02014.x · Cited by 36
Xu, C., Wang, Q., Feng, X., & Bo, Y. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.10.010 · Cited by 32
Takahashi, Y., Nishikawa, M., & Takakura, Y. (2008) · Gene Therapy · doi:10.1038/sj.gt.3303103 · Cited by 32
Becker, T., Ellsworth, R. E., Deyarmin, B., Patney, H. L., Jordan, R. M., Hooke, J. A., Shriver, C. D., & Ellsworth, D. L. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9815-3 · Cited by 32
Cell Migration and Invadopodia Formation Require a Membrane-binding Domain of CARMIL2
Lanier, M. H., McConnell, P., & Cooper, J. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.676882 · Cited by 34
MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R
WANG, X., Li, H., CUI, L., FENG, J., & FAN, Q. (2016) · Neoplasma · doi:10.4149/neo_2016_508 · Cited by 32
Plonczak, A. M., Marco, A. N. D., Dina, R. E., Gujral, D. M., & Palazzo, F. F. (2017) · Journal of Medical Case Reports · doi:10.1186/s13256-017-1441-x · Cited by 32
Tyran, M., Carbuccia, N., Garnier, S., Guillé, A., Adélaïde, J., Finetti, P., Touzlian, J., Viens, P., Tallet, A. R., Gonçalvès, A., et al. (2019) · Cancers · doi:10.3390/cancers11050665 · Cited by 33
“In breast cancer, the triple-negative (TN) and Human Epidermal Growth Factor Receptor-2 HER2/ERBB2-positive molecular subtypes are at a higher risk of BM [5], but the molecular bases of this tropism remain poorly understood.”
BackgroundA Drosera-bioinspired hydrogel for catching and killing cancer cells
Li, S., Chen, N., Gaddes, E. R., Zhang, X., Dong, C., & Wang, Y. (2015) · Scientific Reports · doi:10.1038/srep14297 · Cited by 34
Zhang, N., Liang, X., Gao, C., Chen, M., Zhou, Y., Krueger, C. J., Bao, G., Gong, Z., & Dai, Z. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b11723 · Cited by 33
Lobos‐González, L., Bustos, R., Campos, A. V., Silva, V., Silva, V., Jeldes, E., Salomón, C., Varas‐Godoy, M., Cáceres‐Verschae, A., Durán-Jara, E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57018-1 · Cited by 31
Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases
Escuín, D., López-Vilaró, L., Móra, J., Bell, O. L., Moral, A., Pérez, I., Arqueros, C., García-Valdecasas, B., y Cajal, T. R., Lerma, E., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.627811 · Cited by 35
C/EBPβ/AEP Signaling Regulates the Oxidative Stress in Malignant Cancers, Stimulating the Metastasis
Lei, K., Kang, S. S., Ahn, E. H., Chen, C., Liao, J., Liu, X., Li, H., Edgington‐Mitchell, L. E., Jin, L., & Ye, K. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0019 · Cited by 41
Luo, S., Luo, X., Wang, X., Li, L., Liu, H., Mo, B., Gan, H., Sun, W. Y., Wang, L., Liang, H., et al. (2022) · Small · doi:10.1002/smll.202201298 · Cited by 33
Shen, J., Huang, Q., Jia, W., Feng, S., Liu, L., Li, X., Tao, D., & Xie, D. (2021) · Oncogene · doi:10.1038/s41388-022-02344-4 · Cited by 33
Lu, Z., Ma, L., Mei, L., Ren, K., Li, M., Zhang, L., Liu, X., & He, Q. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122303 · Cited by 32
Wu, D. Q., Zhang, Z., Li, X., Zhou, J., Cao, Y., Qi, S., Wang, L., Liu, Z., & Yu, G. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.07.022 · Cited by 31
Moghtaderi, H., Sadeghian, G., Abiri, H., Khan, F., Rahman, M. M., Al‐Harrasi, A., & Rahman, S. M. (2024) · Sensors and Actuators Reports · doi:10.1016/j.snr.2024.100188 · Cited by 33
Src activates Abl to augment Robo1 expression in order to promote tumor cell migration
Khusial, P. R., Vadla, B., Krishnan, H., Ramlall, T. F., Shen, Y., Ichikawa, H., Geng, J.-G., & Goldberg, G. S. (2010) · Oncotarget · doi:10.18632/oncotarget.126 · Cited by 31
Bemmo, A., Dias, C., Rose, A. A. N., Russo, C., Siegel, P. M., & Majewski, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011981 · Cited by 34
“In breast cancer patients, tumor metastases at distant sites are the main cause of death [1].”
BackgroundThe antiangiogenic activities of ethanolic crude extracts of four Salvia species
Zihlif, M., Afifi‐Yazar, F. Ü., Abu‐Dahab, R., Majid, A. M. S. A., Somrain, H., Saleh, M. M., Nassar, Z. D., & Naffa, R. G. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-358 · Cited by 35
Mathematical Modeling of the Metastatic Process
Scott, J. G., Gerlee, P., Basanta, D., Fletcher, A. G., Maini, P. K., & Anderson, A. R. A. (2013) · Springer eBooks · doi:10.1007/978-94-007-7835-1_9 · Cited by 31
“Metastasis accounts for 90% of cancer related deaths [1], and the shift from localized to metastatic disease represents a paradigm shift for clinicians and patients alike as the strategy for therapy changes from aggressive and localized, to systemic and generally palliative.”
BackgroundLeung, H.-W., Zhao, S., Yue, G. G., Lee, J. K.-M., Fung, K., Leung, P., Tan, N., & Lau, C. B. (2015) · Scientific Reports · doi:10.1038/srep16985 · Cited by 31
Sindhura, B. R., Hegde, P., Chachadi, V. B., Inamdar, S. R., & Swamy, B. M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.081 · Cited by 31
Breunig, C., Erdem, N., Bott, A., Greiwe, J. F., Reinz, E., Bernhardt, S., Giacomelli, C., Wachter, A., Kanthelhardt, E. J., Beißbarth, T., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12355 · Cited by 32
Metadata
- Authors
- Weigelt, B., Peterse, J. L., & van't Veer, L. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- ORCID
- Weigelt, Britta
- Venue
- Nature Reviews Cancer
- Published
- 2005-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 591-602
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2004280628
- Semantic Scholar
- 3bd1490d7b6c8daa59bd35260c6c71e39d3d62fa
- Cited by
- 2,232
- References
- 112
- Citations by year
- 2026: 34 · 2025: 69 · 2024: 90 · 2023: 111 · 2022: 139 · 2021: 154 · 2020: 159 · 2019: 147 · 2018: 140 · 2017: 191 · 2016: 162 · 2015: 152 · 2014: 121 · 2013: 104 · 2012: 88
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- breast cancer, metastasis, prognostic factors, metastatic potential, lymph node metastasis, distant metastasis, carcinogenesis, DNA microarrays, systemic disease, metastasis model
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplasm Metastasis, Biomarkers, Tumor, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.